You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

This website uses cookies

By continuing to use this website you consent to using cookies. For more information about cookies and how we use them, please see our Privacy Policy.

How can your patients benefit from an extracorporeal life support system?

The CARDIOHELP System is a compact heart-lung support system suitable for all indications requiring extracorporeal circulation for cardiopulmonary support. It can be used for up to 30 days in cases of myocardial or respiratory failure resulting from manifold aetiologic factors. The portable CARDIOHELP System is rapidly deployable, making it ideal for transporting patients who require respiratory and/or circulatory support.

The CARDIOHELP System allows vital extracorporeal gas exchange and circulatory support for a period of use of up to 30 days and therefore can be used for various conditions of an ICU patient.

Giving the organs time to heal

Although extracorporeal life support provided by the CARDIOHELP System is not a therapy itself, it acts as a bridge for recovery or transplantation, enabling caregivers to optimize the patient’s therapy. In cases of respiratory support, the extracorporeal circuit provided in a critical care unit enables the use of ultra-protective ventilation to optimize the therapy of acute respiratory distress syndromes (ARDS).  The CARDIOHELP System can also act as cardiac support system until the myocardium recovers after an acute myocardial infarction

Gentle and effective treatment

Treatment with the CARDIOHELP System is much gentler on patients than other existing forms of treatment. Thanks to the low volume of the extracorporeal circulation, the blood comes in contact with less foreign surface area, minimizing blood trauma. Furthermore, less volume of priming fluid is required to fill the extracorporeal circuit.

 

“Since the patient can remain attached to the same system for the duration of treatment, the CARDIOHELP System is also cost-effective.”

There are many treatment options

Extracorporeal circulation can be set up using either veno-venous or veno-arterial cannulation to support cardiac and/or pulmonary function. Support can be extended to complete substitution of the organ function. Indeed an optimum treatment of these patient groups requires a logical, well adapted treatment with optimized ventilation techniques. Even during intra- or inter-hospital transportation, the portable system guarantees adequate patient oxygen supply and CO2 reduction to enable the best organ perfusion possible for the patient.

Get more information on CARDIOHELP product page

How do you transfer patients in need of extracorporeal support?

Patients with serious cardiac or pulmonary compromise require immediate stabilization and transfer.  Clinicians gain valuable time with the CARDIOHELP System, a multi-therapy heart-lung assist system which can be rapidly deployed and used for a wide range of indications in intensive care, emergency medicine, cardiology and cardiac surgery.

Extracorporeal life support system onboard an F-16 fighter

Getinge’s CARDIOHELP System is one of the few portable heart-lung support systems providing ECLS to support circulation and respiration in patients. It’s small enough to be transported in an F-16 fighter!

Learn more about the CARDIOHELP System

For patients needing ECLS, every second counts

There was not much hope for a patient in Bodø in central Norway. The local medical staff lacked the equipment and skills for ECLS. But they knew that a hospital in Trondheim did have the necessary equipment — about 280 miles away. To guarantee a fast transport they contacted the air force for help.

The CARDIOHELP System, along with the necessary equipment and team, arrived after 40 minutes in Bodø. They successfully stabilized the patient for six days using the CARDIOHELP System.

Read more about the incident:

Reduction of blood CO₂

Facilitating protective ventilation strategies, even in severe cases of acute respiratory failure

The veno-venous use of the CARDIOHELP System ensures an effective oxygen supply and/or the reduction of blood CO2 level in intensive care patients suffering from ARDS, sepsis or other indications associated with acute respiratory failure.

Literature list

Performance and Safety of an Integrated Portable Extracorporeal Life Support System for Adults.
Alwardt CM, Wilson DS, Alore ML, Lanza LA, Devaleria PA, Pajaro OE.
J Extra Corpor Technol. 2015 Mar;47(1):38-43.

Portable miniaturized extracorporeal membrane oxygenation systems for H1N1-related severe acute respiratory distress syndrome: a case series.
Roncon-Albuquerque R Jr, Basílio C, Figueiredo P, Silva S, Mergulhão P, Alves C, Veiga R, Castelo-Branco S, Paiva L, Santos L, Honrado T, Dias C, Oliveira T, Sarmento A, Mota AM, Paiva JA.
J Crit Care. 2012 Oct;27(5):454-63. doi: 10.1016/j.jcrc.2012.01.008. Epub 2012 Mar 3

First experience with the ultra compact mobile extracorporeal membrane oxygenation system Cardiohelp in interhospital transport.
Philipp A, Arlt M, Amann M, Lunz D, Müller T, Hilker M, Graf B, Schmid C.
Interact Cardiovasc Thorac Surg. 2011 Jun;12(6):978-81. doi: 10.1510/icvts.2010.264630. Epub 2011 Mar 8

Hand-held minimised extracorporeal membrane oxygenation: a new bridge to recovery in patients with out-of-centre cardiogenic shock.
Arlt M, Philipp A, Voelkel S, Camboni D, Rupprecht L, Graf BM, Schmid C, Hilker M.
Eur J Cardiothorac Surg. 2011 Sep;40(3):689-94. doi: 10.1016/j.ejcts.2010.12.055. Epub 2011 Feb 23.

Temporary Venoarterial Extracorporeal Membrane Oxygenation: Ten-Year Experience at a Cardiac Transplant Center.
Tran BG, De La Cruz K, Grant S, Meltzer J, Benharash P, Dave R, Ardehali A, Shemin R, Depasquale E, Nsair A.
J Intensive Care Med. 2016 Jun 14. pii: 0885066616654451. [Epub ahead of print

Extracorporeal membrane oxygenation 2016: an update.
Butt W, MacLaren G.
F1000Res. 2016 Apr 26;5. pii: F1000 Faculty Rev-750. doi: 10.12688/f1000research.8320.1. eCollection 2016. Review.
PMID: 27158464